U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It provides workforce performance solutions, including onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments for Fortune 500 companies, and other clients comprising insurers and their contractors. As of March 13, 2018, it operated 579 outpatient physical therapy clinics in 42 states; and managed 28 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The company was founded in 1990 and is based in Houston, Texas.
Industry, Sector and Symbol
Industry Health services
Sub-IndustryHealth Care Facilities
SectorMedical
Phone713-297-7000
Debt
Current Ratio1.93
Quick Ratio1.93
Price-To-Earnings
Sales & Book Value
Annual Sales$414.05 million
Price / Sales3.28
Price / Cash Flow35.79
Price / Book6.54
Profitability
Net Income$22.25 million
Net Margins5.58%
Return on Assets8.56%
Miscellaneous
Employees4,300
OptionableOptionable
U.S. Physical Therapy (NYSE:USPH) Frequently Asked Questions
What is U.S. Physical Therapy's stock symbol?
U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."
How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?
U.S. Physical Therapy announced a quarterly dividend on Thursday, November 1st. Investors of record on Friday, November 9th will be given a dividend of $0.23 per share on Friday, December 7th. This represents a $0.92 annualized dividend and a yield of 0.86%. The ex-dividend date is Thursday, November 8th. View U.S. Physical Therapy's Dividend History.
How were U.S. Physical Therapy's earnings last quarter?
U.S. Physical Therapy, Inc. (NYSE:USPH) released its quarterly earnings results on Thursday, November, 1st. The company reported $0.64 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.58 by $0.06. The firm earned $113.10 million during the quarter, compared to analyst estimates of $112.79 million. U.S. Physical Therapy had a return on equity of 17.64% and a net margin of 5.58%. The business's quarterly revenue was up 9.8% on a year-over-year basis. View U.S. Physical Therapy's Earnings History.
When is U.S. Physical Therapy's next earnings date?
What guidance has U.S. Physical Therapy issued on next quarter's earnings?
U.S. Physical Therapy issued an update on its FY18 earnings guidance on Thursday, November, 1st. The company provided earnings per share guidance of $2.50-2.57 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.52.
What price target have analysts set for USPH?
4 equities research analysts have issued twelve-month price objectives for U.S. Physical Therapy's stock. Their forecasts range from $105.00 to $107.00. On average, they expect U.S. Physical Therapy's stock price to reach $106.00 in the next twelve months. This suggests that the stock has a possible downside of 1.1%. View Analyst Price Targets for U.S. Physical Therapy.
What is the consensus analysts' recommendation for U.S. Physical Therapy?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for U.S. Physical Therapy.
What are Wall Street analysts saying about U.S. Physical Therapy stock?
Here are some recent quotes from research analysts about U.S. Physical Therapy stock:
- 1. According to Zacks Investment Research, "U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders. " (8/7/2018)
- 2. Barrington Research analysts commented, "We are maintaining our MARKET PERFORM investment rating on USPH shares due to valuation concerns. This is genuinely frustrating because we continue to really like this business and its management team. That said, to hold a constructive investment rating on USPH shares, we would need to assign more than a 23.5x EV/EBITDA multiple to our 2019 estimate. As much as we like the company, such a valuation seems a bit much." (8/3/2018)
- 3. Cantor Fitzgerald analysts commented, "1Q18 results were in-line with our expectations, driven by a 7.4% jump in patient visits, new practices and a full quarter’s contribution from its workforce performance solutions business." (5/3/2018)
Has U.S. Physical Therapy been receiving favorable news coverage?
Media coverage about USPH stock has been trending somewhat negative this week, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. U.S. Physical Therapy earned a media sentiment score of -1.2 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an impact on the stock's share price in the next several days.
Who are some of U.S. Physical Therapy's key competitors?
Some companies that are related to U.S. Physical Therapy include Hikma Pharmaceuticals (HKMPF), GALAPAGOS NV/S (GLPG), Haemonetics (HAE), Alkermes (ALKS), United Therapeutics (UTHR), Syneos Health (SYNH), Catalent (CTLT), ORION OYJ/ADR (ORINY), ASPEN PHARMACAR/ADR (APNHY), ICU Medical (ICUI), DiaSorin (DSRLF), ELEKTA AB/ADR (EKTAY), Chemed (CHE), Penumbra (PEN) and Insulet (PODD).
Who are U.S. Physical Therapy's key executives?
U.S. Physical Therapy's management team includes the folowing people:
- Mr. Christopher J. Reading, Pres, CEO & Director (Age 54)
- Mr. Lawrance W. McAfee, Exec. VP, CFO & Director (Age 63)
- Mr. Glenn D. McDowell, Chief Operating Officer of West (Age 61)
- Mr. Graham Reeve M.B.A., P.T., Chief Operating Officer of East (Age 54)
- Mr. Jon C. Bates, VP & Corp. Controller
Who are U.S. Physical Therapy's major shareholders?
U.S. Physical Therapy's stock is owned by many different of retail and institutional investors. Top institutional investors include Riverbridge Partners LLC (3.59%), Scout Investments Inc. (0.53%) and Louisiana State Employees Retirement System (0.04%). Company insiders that own U.S. Physical Therapy stock include Bernard A Harris Jr, Christopher J Reading, Clayton Trier, Edward L Kuntz, Glenn Mcdowell, Harry S Chapman, Jerald L Pullins, Lawrance W Mcafee, Mark J Brookner and Regg E Swanson. View Institutional Ownership Trends for U.S. Physical Therapy.
Which institutional investors are selling U.S. Physical Therapy stock?
USPH stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Scout Investments Inc. and Louisiana State Employees Retirement System. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Bernard A Harris Jr, Christopher J Reading, Clayton Trier, Edward L Kuntz, Glenn Mcdowell, Jerald L Pullins, Lawrance W Mcafee and Mark J Brookner. View Insider Buying and Selling for U.S. Physical Therapy.
How do I buy shares of U.S. Physical Therapy?
Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is U.S. Physical Therapy's stock price today?
One share of USPH stock can currently be purchased for approximately $107.17.
How big of a company is U.S. Physical Therapy?
U.S. Physical Therapy has a market capitalization of $1.30 billion and generates $414.05 million in revenue each year. The company earns $22.25 million in net income (profit) each year or $2.08 on an earnings per share basis. U.S. Physical Therapy employs 4,300 workers across the globe.
What is U.S. Physical Therapy's official website?
How can I contact U.S. Physical Therapy?
U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at 713-297-7000 or via email at [email protected]
MarketBeat Community Rating for U.S. Physical Therapy (NYSE USPH)
MarketBeat's community ratings are surveys of what our community members think about U.S. Physical Therapy and other stocks. Vote "Outperform" if you believe USPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe USPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
